Defining mild cognitive impairment: Impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates

John A. Schinka, David Loewenstein, Ashok Raj, Mike R. Schoenberg, Jessica L. Banko, Huntington Potter, Ranjan Duara

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective: To examine the impact of varying decision criteria on neuropsychological diagnostic frequencies and on their correlates. Design: Descriptive and correlational study. Setting: Florida Alzheimer,s Disease Research Center. Participants: A sample of 373 individuals with comprehensive baseline analyses participating in a longitudinal study of cognitive decline and early Alzheimer disease. Measurements: Mild cognitive impairment (MCI) diagnoses were made on the basis of four sets of decision criteria created by crossing two approaches: varying the number of impaired test Results required for a diagnosis within any domain (1 test versus 2) and varying the performance level required to determine impairment (1.5 or 2 standard deviations [SDs] below the normative mean) for any test. Results: Under each criteria set, single-domain amnestic MCI was the most frequent MCI diagnosis. MCI global and subtype diagnosis frequencies were inversely related to the stringency of the criteria. The single test-1.5 SD criterion identified the largest number of cases as qualifying for an MCI diagnosis, and the two test-2.0 SD cutoff identified the fewest. Across all sets of criteria, the authors found significant positive associations between neuropsychological diagnoses and Clinical Dementia Rating score categories. Significant relationships between diagnoses and both apolipoprotein E (APOE) genotype and magnetic resonance imaging ratings of medial temporal atrophy (MTA) application were found only for the two test-1.5 SD and two test-2.0 SD cutoffs. Conclusion: MCI diagnosis frequencies are substantively affected by the stringency of the criteria, but the relative rankings of MCI subtype diagnoses are fairly consistent regardless of the stringency of the criteria. Significant associations of neuropsychological diagnoses with independent markers such as APOE genotype and MTA are only found with more stringent criteria, suggesting that a coherent network of associations reflecting cognitive decline occurs with more restrictive definitions for impairment.

Original languageEnglish
Pages (from-to)684-691
Number of pages8
JournalAmerican Journal of Geriatric Psychiatry
Volume18
Issue number8
DOIs
StatePublished - Aug 1 2010

Fingerprint

Apolipoproteins E
Atrophy
Alzheimer Disease
Genotype
Cognitive Dysfunction
Longitudinal Studies
Dementia
Magnetic Resonance Imaging
Research

Keywords

  • aging
  • Alzheimer disease
  • cognition
  • Mild cognitive impairment
  • neuropsychological tests

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology

Cite this

Defining mild cognitive impairment : Impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. / Schinka, John A.; Loewenstein, David; Raj, Ashok; Schoenberg, Mike R.; Banko, Jessica L.; Potter, Huntington; Duara, Ranjan.

In: American Journal of Geriatric Psychiatry, Vol. 18, No. 8, 01.08.2010, p. 684-691.

Research output: Contribution to journalArticle

Schinka, John A. ; Loewenstein, David ; Raj, Ashok ; Schoenberg, Mike R. ; Banko, Jessica L. ; Potter, Huntington ; Duara, Ranjan. / Defining mild cognitive impairment : Impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. In: American Journal of Geriatric Psychiatry. 2010 ; Vol. 18, No. 8. pp. 684-691.
@article{fbc70e17620a46b785b4c2371f0461d5,
title = "Defining mild cognitive impairment: Impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates",
abstract = "Objective: To examine the impact of varying decision criteria on neuropsychological diagnostic frequencies and on their correlates. Design: Descriptive and correlational study. Setting: Florida Alzheimer,s Disease Research Center. Participants: A sample of 373 individuals with comprehensive baseline analyses participating in a longitudinal study of cognitive decline and early Alzheimer disease. Measurements: Mild cognitive impairment (MCI) diagnoses were made on the basis of four sets of decision criteria created by crossing two approaches: varying the number of impaired test Results required for a diagnosis within any domain (1 test versus 2) and varying the performance level required to determine impairment (1.5 or 2 standard deviations [SDs] below the normative mean) for any test. Results: Under each criteria set, single-domain amnestic MCI was the most frequent MCI diagnosis. MCI global and subtype diagnosis frequencies were inversely related to the stringency of the criteria. The single test-1.5 SD criterion identified the largest number of cases as qualifying for an MCI diagnosis, and the two test-2.0 SD cutoff identified the fewest. Across all sets of criteria, the authors found significant positive associations between neuropsychological diagnoses and Clinical Dementia Rating score categories. Significant relationships between diagnoses and both apolipoprotein E (APOE) genotype and magnetic resonance imaging ratings of medial temporal atrophy (MTA) application were found only for the two test-1.5 SD and two test-2.0 SD cutoffs. Conclusion: MCI diagnosis frequencies are substantively affected by the stringency of the criteria, but the relative rankings of MCI subtype diagnoses are fairly consistent regardless of the stringency of the criteria. Significant associations of neuropsychological diagnoses with independent markers such as APOE genotype and MTA are only found with more stringent criteria, suggesting that a coherent network of associations reflecting cognitive decline occurs with more restrictive definitions for impairment.",
keywords = "aging, Alzheimer disease, cognition, Mild cognitive impairment, neuropsychological tests",
author = "Schinka, {John A.} and David Loewenstein and Ashok Raj and Schoenberg, {Mike R.} and Banko, {Jessica L.} and Huntington Potter and Ranjan Duara",
year = "2010",
month = "8",
day = "1",
doi = "10.1097/JGP.0b013e3181e56d5a",
language = "English",
volume = "18",
pages = "684--691",
journal = "American Journal of Geriatric Psychiatry",
issn = "1064-7481",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Defining mild cognitive impairment

T2 - Impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates

AU - Schinka, John A.

AU - Loewenstein, David

AU - Raj, Ashok

AU - Schoenberg, Mike R.

AU - Banko, Jessica L.

AU - Potter, Huntington

AU - Duara, Ranjan

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Objective: To examine the impact of varying decision criteria on neuropsychological diagnostic frequencies and on their correlates. Design: Descriptive and correlational study. Setting: Florida Alzheimer,s Disease Research Center. Participants: A sample of 373 individuals with comprehensive baseline analyses participating in a longitudinal study of cognitive decline and early Alzheimer disease. Measurements: Mild cognitive impairment (MCI) diagnoses were made on the basis of four sets of decision criteria created by crossing two approaches: varying the number of impaired test Results required for a diagnosis within any domain (1 test versus 2) and varying the performance level required to determine impairment (1.5 or 2 standard deviations [SDs] below the normative mean) for any test. Results: Under each criteria set, single-domain amnestic MCI was the most frequent MCI diagnosis. MCI global and subtype diagnosis frequencies were inversely related to the stringency of the criteria. The single test-1.5 SD criterion identified the largest number of cases as qualifying for an MCI diagnosis, and the two test-2.0 SD cutoff identified the fewest. Across all sets of criteria, the authors found significant positive associations between neuropsychological diagnoses and Clinical Dementia Rating score categories. Significant relationships between diagnoses and both apolipoprotein E (APOE) genotype and magnetic resonance imaging ratings of medial temporal atrophy (MTA) application were found only for the two test-1.5 SD and two test-2.0 SD cutoffs. Conclusion: MCI diagnosis frequencies are substantively affected by the stringency of the criteria, but the relative rankings of MCI subtype diagnoses are fairly consistent regardless of the stringency of the criteria. Significant associations of neuropsychological diagnoses with independent markers such as APOE genotype and MTA are only found with more stringent criteria, suggesting that a coherent network of associations reflecting cognitive decline occurs with more restrictive definitions for impairment.

AB - Objective: To examine the impact of varying decision criteria on neuropsychological diagnostic frequencies and on their correlates. Design: Descriptive and correlational study. Setting: Florida Alzheimer,s Disease Research Center. Participants: A sample of 373 individuals with comprehensive baseline analyses participating in a longitudinal study of cognitive decline and early Alzheimer disease. Measurements: Mild cognitive impairment (MCI) diagnoses were made on the basis of four sets of decision criteria created by crossing two approaches: varying the number of impaired test Results required for a diagnosis within any domain (1 test versus 2) and varying the performance level required to determine impairment (1.5 or 2 standard deviations [SDs] below the normative mean) for any test. Results: Under each criteria set, single-domain amnestic MCI was the most frequent MCI diagnosis. MCI global and subtype diagnosis frequencies were inversely related to the stringency of the criteria. The single test-1.5 SD criterion identified the largest number of cases as qualifying for an MCI diagnosis, and the two test-2.0 SD cutoff identified the fewest. Across all sets of criteria, the authors found significant positive associations between neuropsychological diagnoses and Clinical Dementia Rating score categories. Significant relationships between diagnoses and both apolipoprotein E (APOE) genotype and magnetic resonance imaging ratings of medial temporal atrophy (MTA) application were found only for the two test-1.5 SD and two test-2.0 SD cutoffs. Conclusion: MCI diagnosis frequencies are substantively affected by the stringency of the criteria, but the relative rankings of MCI subtype diagnoses are fairly consistent regardless of the stringency of the criteria. Significant associations of neuropsychological diagnoses with independent markers such as APOE genotype and MTA are only found with more stringent criteria, suggesting that a coherent network of associations reflecting cognitive decline occurs with more restrictive definitions for impairment.

KW - aging

KW - Alzheimer disease

KW - cognition

KW - Mild cognitive impairment

KW - neuropsychological tests

UR - http://www.scopus.com/inward/record.url?scp=77955173439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955173439&partnerID=8YFLogxK

U2 - 10.1097/JGP.0b013e3181e56d5a

DO - 10.1097/JGP.0b013e3181e56d5a

M3 - Article

C2 - 21399729

AN - SCOPUS:77955173439

VL - 18

SP - 684

EP - 691

JO - American Journal of Geriatric Psychiatry

JF - American Journal of Geriatric Psychiatry

SN - 1064-7481

IS - 8

ER -